• Return to Headlines

Best Relative Performance in the Biotechnology Industry Detected in Shares of Myriad Genetics (MYGN , ACOR , KPTI , INSM , CYTK )

By Amy Schwartz

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Myriad Genetics (NASDAQ:MYGN ) ranks first with a gain of 8.43%; Acorda Therapeut (NASDAQ:ACOR ) ranks second with a gain of 6.89%; and Karyopharm Thera (NASDAQ:KPTI ) ranks third with a gain of 5.89%.

Insmed Inc (NASDAQ:INSM ) follows with a gain of 5.69% and Cytokinetics Inc (NASDAQ:CYTK ) rounds out the top five with a gain of 4.74%.

SmarTrend recommended that subscribers consider buying shares of Cytokinetics Inc on March 14th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $7.30. Since that recommendation, shares of Cytokinetics Inc have risen 30.0%. We continue to monitor Cytokinetics Inc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance myriad genetics acorda therapeut karyopharm thera insmed inc cytokinetics inc

Ticker(s): MYGN ACOR KPTI INSM CYTK